We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




UK Government Initiates Competition to Map Rare Cancer Genes

By LabMedica International staff writers
Posted on 17 Dec 2013
A GBP 10 million competition has been established to help biotech companies develop advanced technology to map and analyze genes.

Companies that win the competition will be funded to develop high-tech products to help identify and treat inherited diseases and cancer. More...
Concepts could include new computer code or hardware, or enhancement of existing software and technology. 

The competition will run together with plans to map the DNA code of up to 100,000 UK National Health Service (NHS) patients with cancer and rare diseases by 2017. The products developed as part of the competition will play a part in reaching this goal. Public Health England (London, UK) is also leading work to use whole genome sequencing to treat infectious diseases.

UK Heath Minister Lord Howe said, “Our plans to map 100,000 genomes over the next five years will lead to truly ground-breaking discoveries about how diseases work and how we can treat them more effectively. This competition helps harness the creativity and ingenuity of businesses to help us reach our target. Our investment in pioneering scientific research is good news for patients, for the research sector and for the economy, creating jobs and growth in our world-beating life sciences industry, and helping the UK compete in the global race.”

The competition is part of the Government’s commitment to making the United Kingdom one of the best places to start and grow a business. Application forms and additional details about this competition can be found online (please see Related Links below). The deadline for entries is February 5, 2014. Winning proposals will be announced in March 2014.

The UK Department of Health (DH; London, UK) is funding the competition through the Small Business Research Initiative (SBRI). 

Related Links:

Public Health England
UK Department of Health
Technology Strategy Board

 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.